L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic:
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
[Auckland u.a.]
Adis
2019
|
| Schriftenreihe: | Supplement
1 |
| Schlagworte: | |
| Beschreibung: | 44 Seiten Illustrationen |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV045529836 | ||
| 003 | DE-604 | ||
| 005 | 20190327 | ||
| 007 | t | ||
| 008 | 190326s2019 a||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)1090779547 | ||
| 035 | |a (DE-599)BVBBV045529836 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 245 | 1 | 0 | |a L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic |c guest ed.: Roger F. Butterworth |
| 264 | 1 | |a [Auckland u.a.] |b Adis |c 2019 | |
| 300 | |a 44 Seiten |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drugs. Supplement |v vol. 79 |a Supplement |v 1 | |
| 650 | 0 | 7 | |a Encephalopathia hepatica |0 (DE-588)4130645-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Ornithin-Aspartat |0 (DE-588)4313366-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Encephalopathia hepatica |0 (DE-588)4130645-4 |D s |
| 689 | 0 | 1 | |a Ornithin-Aspartat |0 (DE-588)4313366-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Butterworth, Roger F. |0 (DE-588)171998014 |4 edt | |
| 830 | 0 | |a Supplement |v 1 |w (DE-604)BV000904909 |9 79,1 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030913977 | ||
Datensatz im Suchindex
| _version_ | 1804179487398559744 |
|---|---|
| any_adam_object | |
| author2 | Butterworth, Roger F. |
| author2_role | edt |
| author2_variant | r f b rf rfb |
| author_GND | (DE-588)171998014 |
| author_facet | Butterworth, Roger F. |
| building | Verbundindex |
| bvnumber | BV045529836 |
| ctrlnum | (OCoLC)1090779547 (DE-599)BVBBV045529836 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01252nam a2200337 cb4500</leader><controlfield tag="001">BV045529836</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190327 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">190326s2019 a||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1090779547</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045529836</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic</subfield><subfield code="c">guest ed.: Roger F. Butterworth</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Auckland u.a.]</subfield><subfield code="b">Adis</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">44 Seiten</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs. Supplement</subfield><subfield code="v">vol. 79</subfield><subfield code="a">Supplement</subfield><subfield code="v">1</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Encephalopathia hepatica</subfield><subfield code="0">(DE-588)4130645-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ornithin-Aspartat</subfield><subfield code="0">(DE-588)4313366-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Encephalopathia hepatica</subfield><subfield code="0">(DE-588)4130645-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Ornithin-Aspartat</subfield><subfield code="0">(DE-588)4313366-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Butterworth, Roger F.</subfield><subfield code="0">(DE-588)171998014</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Supplement</subfield><subfield code="v">1</subfield><subfield code="w">(DE-604)BV000904909</subfield><subfield code="9">79,1</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030913977</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV045529836 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T08:20:39Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030913977 |
| oclc_num | 1090779547 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 44 Seiten Illustrationen |
| publishDate | 2019 |
| publishDateSearch | 2019 |
| publishDateSort | 2019 |
| publisher | Adis |
| record_format | marc |
| series | Supplement |
| series2 | Drugs. Supplement Supplement |
| spelling | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic guest ed.: Roger F. Butterworth [Auckland u.a.] Adis 2019 44 Seiten Illustrationen txt rdacontent n rdamedia nc rdacarrier Drugs. Supplement vol. 79 Supplement 1 Encephalopathia hepatica (DE-588)4130645-4 gnd rswk-swf Ornithin-Aspartat (DE-588)4313366-6 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Encephalopathia hepatica (DE-588)4130645-4 s Ornithin-Aspartat (DE-588)4313366-6 s DE-604 Butterworth, Roger F. (DE-588)171998014 edt Supplement 1 (DE-604)BV000904909 79,1 |
| spellingShingle | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic Supplement Encephalopathia hepatica (DE-588)4130645-4 gnd Ornithin-Aspartat (DE-588)4313366-6 gnd |
| subject_GND | (DE-588)4130645-4 (DE-588)4313366-6 (DE-588)4143413-4 |
| title | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic |
| title_auth | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic |
| title_exact_search | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic |
| title_full | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic guest ed.: Roger F. Butterworth |
| title_fullStr | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic guest ed.: Roger F. Butterworth |
| title_full_unstemmed | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic guest ed.: Roger F. Butterworth |
| title_short | L-Ornithine L-Aspartate (LOLA) for the treatment of hepatic encephalopathy in cirrhosis: Novel insights and traslation to the clinic |
| title_sort | l ornithine l aspartate lola for the treatment of hepatic encephalopathy in cirrhosis novel insights and traslation to the clinic |
| topic | Encephalopathia hepatica (DE-588)4130645-4 gnd Ornithin-Aspartat (DE-588)4313366-6 gnd |
| topic_facet | Encephalopathia hepatica Ornithin-Aspartat Aufsatzsammlung |
| volume_link | (DE-604)BV000904909 |
| work_keys_str_mv | AT butterworthrogerf lornithinelaspartatelolaforthetreatmentofhepaticencephalopathyincirrhosisnovelinsightsandtraslationtotheclinic |